• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于血液透析的中心静脉导管——神话与证据

Central Venous Catheters for Hemodialysis-the Myth and the Evidence.

作者信息

Sohail Mohammad Ahsan, Vachharajani Tushar J, Anvari Evamaria

机构信息

Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.

出版信息

Kidney Int Rep. 2021 Oct 11;6(12):2958-2968. doi: 10.1016/j.ekir.2021.09.009. eCollection 2021 Dec.

DOI:10.1016/j.ekir.2021.09.009
PMID:34901568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8640568/
Abstract

Hemodialysis-central venous catheter (HD-CVC) insertion is a most often performed procedure, with approximately 80% of patients with end-stage kidney disease in the United States initiating kidney replacement therapy through a HD-CVC. Certain adverse events arising from HD-CVC placement, including catheter-related bloodstream infections (CR-BSIs), thrombosis, and central vein stenosis, can complicate the clinical course of patients and lead to considerable financial impact on the health care system. Medical professionals with different training backgrounds are responsible for performing this procedure, and therefore, comprehensive operator guidelines are crucial to improve the success rate of HD-CVC insertion and prevent complications. In this review article, we not only discuss the basic principles behind the use of HD-CVCs but also address frequently asked questions and myths regarding catheter asepsis, length selection, tip positioning, and flow rate assessment.

摘要

血液透析中心静脉导管(HD-CVC)置入是一种最常进行的操作,在美国约80%的终末期肾病患者通过HD-CVC开始肾脏替代治疗。HD-CVC置入引发的某些不良事件,包括导管相关血流感染(CR-BSIs)、血栓形成和中心静脉狭窄,可使患者的临床病程复杂化,并给医疗保健系统带来相当大的经济影响。具有不同培训背景的医学专业人员负责执行此操作,因此,全面的操作指南对于提高HD-CVC置入成功率和预防并发症至关重要。在这篇综述文章中,我们不仅讨论了使用HD-CVC的基本原则,还解答了有关导管无菌、长度选择、尖端定位和流速评估的常见问题及误解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4af1/8640568/b9a9b3f1e4f4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4af1/8640568/b9a9b3f1e4f4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4af1/8640568/b9a9b3f1e4f4/gr1.jpg

相似文献

1
Central Venous Catheters for Hemodialysis-the Myth and the Evidence.用于血液透析的中心静脉导管——神话与证据
Kidney Int Rep. 2021 Oct 11;6(12):2958-2968. doi: 10.1016/j.ekir.2021.09.009. eCollection 2021 Dec.
2
[Access for starting kidney replacement therapy: vascular and peritoneal temporal access in pre-dialysis].[开始肾脏替代治疗的通路:透析前的血管和腹膜临时通路]
Nefrologia. 2008;28 Suppl 3:105-12.
3
Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study.经皮隧道式血液透析导管相关并发症:加拿大观察性队列研究。
Am J Kidney Dis. 2019 Apr;73(4):467-475. doi: 10.1053/j.ajkd.2018.10.014. Epub 2019 Jan 12.
4
Hemodialysis Catheters in Infants: A Retrospective Single-Center Cohort Study.婴儿血液透析导管:一项回顾性单中心队列研究。
J Vasc Interv Radiol. 2020 May;31(5):778-786. doi: 10.1016/j.jvir.2020.01.020. Epub 2020 Apr 15.
5
Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis.中心静脉或血液透析导管患者导管相关并发症的发生率:一项基于医保索赔数据库的分析。
BMC Cardiovasc Disord. 2013 Oct 16;13:86. doi: 10.1186/1471-2261-13-86.
6
A Novel Inside-out Access Approach for Hemodialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion.一种用于胸内中心静脉阻塞患者行血液透析导管置管的新型内外贯通入路方法。
Am J Kidney Dis. 2020 Apr;75(4):480-487. doi: 10.1053/j.ajkd.2019.08.024. Epub 2019 Nov 29.
7
Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap.透析导管相关血流感染:ClearGuard HD 抗菌屏障帽的一项集群随机试验。
Am J Kidney Dis. 2017 Feb;69(2):220-227. doi: 10.1053/j.ajkd.2016.09.014. Epub 2016 Nov 10.
8
Reduction in catheter-related infections after switching from povidone-iodine to chlorhexidine for the exit-site care of tunneled central venous catheters in children on hemodialysis.对于接受血液透析的儿童,在将用于隧道式中心静脉导管出口部位护理的聚维酮碘更换为氯己定后,导管相关感染有所减少。
Hemodial Int. 2014 Oct;18 Suppl 1:S13-8. doi: 10.1111/hdi.12218.
9
Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.头孢唑林-庆大霉素与牛磺罗定-柠檬酸盐预防血液透析患者隧道式中心导管感染的比较:一项准实验性试验。
Int J Infect Dis. 2019 Aug;85:16-21. doi: 10.1016/j.ijid.2019.05.017. Epub 2019 May 15.
10
Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.血液透析患者中闭塞的隧道式静脉导管:危险因素及阿替普酶的疗效
Artif Organs. 2015 Sep;39(9):741-7. doi: 10.1111/aor.12462. Epub 2015 Apr 20.

引用本文的文献

1
Evaluating tissue plasminogen activator (tPA) in dialysis catheter dysfunction: A focus on fibrin sheath and risk factors.评估组织型纤溶酶原激活剂(tPA)在透析导管功能障碍中的作用:聚焦纤维蛋白鞘及危险因素。
Am Heart J Plus. 2025 Aug 18;58:100595. doi: 10.1016/j.ahjo.2025.100595. eCollection 2025 Oct.
2
Epidemiology of Vascular Access in Patients Undergoing Chronic Hemodialysis Treatment in Greece.希腊接受慢性血液透析治疗患者的血管通路流行病学
J Clin Med. 2025 Jun 27;14(13):4571. doi: 10.3390/jcm14134571.
3
The current status and evolution of hemodialysis catheters.

本文引用的文献

1
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update.KDIGO 临床实践指南:血管通路 2019 更新版。
Am J Kidney Dis. 2020 Apr;75(4 Suppl 2):S1-S164. doi: 10.1053/j.ajkd.2019.12.001. Epub 2020 Mar 12.
2
Concomitant placement of dialysis and infusion catheters in the right internal jugular vein in the intensive care setting: Is it safe?在重症监护环境中,同时在右颈内静脉内置入透析和输液导管:安全吗?
J Vasc Access. 2021 May;22(3):359-363. doi: 10.1177/1129729820938209. Epub 2020 Jul 15.
3
The use of 3.15% chlorhexidine gluconate/70% alcohol hub disinfection to prevent central line-associated bloodstream infections in dialysis patients.
血液透析导管的现状与发展
Ren Fail. 2025 Dec;47(1):2524523. doi: 10.1080/0886022X.2025.2524523. Epub 2025 Jul 3.
4
Development and validation of a nomogram risk prediction model for PICC-related thrombosis in children with hematological malignancies.血液系统恶性肿瘤患儿经外周静脉穿刺中心静脉置管相关血栓形成的列线图风险预测模型的构建与验证
Clin Exp Med. 2025 Jun 10;25(1):195. doi: 10.1007/s10238-025-01707-x.
5
Vascular Access Type and Survival Outcomes in Hemodialysis Patients: A Seven-Year Cohort Study.血液透析患者的血管通路类型与生存结局:一项七年队列研究。
Medicina (Kaunas). 2025 Mar 25;61(4):584. doi: 10.3390/medicina61040584.
6
Efficacy of heparin-vancomycin-amikacin combination lock in preventing catheter-related infections in haemodialysis patients: a double-blind randomized clinical trial.肝素-万古霉素-阿米卡星联合封管预防血液透析患者导管相关感染的疗效:一项双盲随机临床试验
Infect Prev Pract. 2025 Mar 14;7(2):100457. doi: 10.1016/j.infpip.2025.100457. eCollection 2025 Jun.
7
The correlation between subcutaneous fat thickness and the incidence of chemoport-related infection.皮下脂肪厚度与化疗端口相关感染发生率之间的相关性。
Infect Prev Pract. 2024 Dec 5;7(1):100433. doi: 10.1016/j.infpip.2024.100433. eCollection 2025 Mar.
8
Evaluating the use of tunneled hemodialysis catheters in the treatment of acute kidney disease patients requiring hemodialysis: a case-control study.评估隧道式血液透析导管在治疗需要血液透析的急性肾疾病患者中的应用:一项病例对照研究。
Int Urol Nephrol. 2025 May;57(5):1609-1614. doi: 10.1007/s11255-024-04292-2. Epub 2024 Nov 21.
9
Nursing and Supply Chain as Critical Partners in Enterprise-Level Efforts to Prevent Hemodialysis Associated Central Line-Associated Blood Stream Infections: A Case Study.护理与供应链在企业层面预防血液透析相关中心静脉导管相关血流感染工作中作为关键合作伙伴:一项案例研究
HCA Healthc J Med. 2024 Oct 1;5(5):587-595. doi: 10.36518/2689-0216.2022. eCollection 2024.
10
Microbiological analysis of tunneled hemodialysis catheters isolated from patients receiving hemodialysis in Saskatchewan.萨斯喀彻温省接受血液透析患者的隧道式血液透析导管的微生物分析。
Future Microbiol. 2024 Sep;19(13):1129-1144. doi: 10.1080/17460913.2024.2359879. Epub 2024 Aug 16.
使用3.15%葡萄糖酸氯己定/70%酒精进行中心静脉导管接头消毒以预防透析患者中心静脉导管相关血流感染。
Br J Nurs. 2020 Jan 23;29(2):S24-S26. doi: 10.12968/bjon.2020.29.2.S24.
4
Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis.血液透析患者的血流感染预防。
Clin J Am Soc Nephrol. 2020 Jan 7;15(1):132-151. doi: 10.2215/CJN.06820619. Epub 2019 Dec 5.
5
US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2019年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2020 Jan;75(1 Suppl 1):A6-A7. doi: 10.1053/j.ajkd.2019.09.003. Epub 2019 Nov 5.
6
Clinical Outcomes and Economic Impact of Starting Hemodialysis with a Catheter after Predialysis Arteriovenous Fistula Creation.经皮血管造瘘术后立即使用导管开始血液透析的临床转归和经济影响。
Am J Nephrol. 2019;50(3):221-227. doi: 10.1159/000502050. Epub 2019 Aug 8.
7
A systematic review and meta-analysis of the comparison of performance among step-tip, split-tip, and symmetrical-tip hemodialysis catheters.一种关于阶梯头、分叉头和对称头血液透析导管性能比较的系统评价和荟萃分析。
J Vasc Surg. 2019 Apr;69(4):1282-1292. doi: 10.1016/j.jvs.2018.09.029.
8
Prevention of hemodialysis catheter infections: Ointments, dressings, locks, and catheter hub devices.血液透析导管感染的预防:软膏、敷料、封管液及导管接头装置
Hemodial Int. 2018 Oct;22(S2):S75-S82. doi: 10.1111/hdi.12703. Epub 2018 Nov 8.
9
Application of Intravascular Ultrasound in End-Stage Renal Patients with Central Venous Occlusive Disease.血管内超声在终末期肾病合并中心静脉闭塞性疾病患者中的应用
Methodist Debakey Cardiovasc J. 2018 Jul-Sep;14(3):196-199. doi: 10.14797/mdcj-14-3-196.
10
Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction: Endorsed by the American Society of Diagnostic and Interventional Nephrology (ASDIN), British Society of Interventional Radiology (BSIR), Canadian Interventional Radiology Association (CIRA), Heart Rhythm Society (HRS), Indian Society of Vascular and Interventional Radiology (ISVIR), Vascular Access Society of the Americas (VASA), and Vascular Access Society of Britain and Ireland (VASBI).介入放射学会关于胸段中心静脉阻塞的报告标准:得到美国诊断与介入肾脏病学会(ASDIN)、英国介入放射学会(BSIR)、加拿大介入放射学会(CIRA)、心律学会(HRS)、印度血管与介入放射学会(ISVIR)、美洲血管通路学会(VASA)以及英国和爱尔兰血管通路学会(VASBI)的认可。
J Vasc Access. 2019 Mar;20(2):114-122. doi: 10.1177/1129729818791409. Epub 2018 Aug 13.